BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Liver
,
Anticancer prodrugs
,
Acetaminophen
,
rs2476601
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
activated b- cell- diffuse large b- cell lymphomas
Summary
General Info
Curated Studies
Most Correlated Studies
Lymphoma (4 types) and B-cell purified subpopulation gene expression profiling
Lymph nodes from diffuse large B-cell lymphoma (DLBCL) patients
EZH2 mutant and wild type DLBCL cell lines treated with a EZH2 inhibitor
Diffuse large B cell lymphoma SU-DHL-6, SU-DHL-4 and Farage cells treated with BCL6 inhibitor FX1
Diffuse large B cell lymphoma cell lines treated with BCL6-inhibitor 79-6.1085
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for activated b- cell- diffuse large b- cell lymphomas
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of…
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell…
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Dif…
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Dif…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ